Apogee Therapeutics, Inc. - APGE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Sep 08, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Sep 03, 2026 | SCHEDULE 13D/A | — | 5.0% | — | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 0.9% | 564,326 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 0.9% | 564,326 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 0.9% | 564,326 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 1.3% | 772,969 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | FMR LLC | 4.0% | 2,493,137 | View |
| Jul 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 4.0% | 2,493,137 | View |
| Jun 23, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.